Taylor Doggett
Medical · New Roads, LANPI 1851084529
Payments from drug & device makers
What this record shows
Inspire Medical Systems, Inc. accounts for 78.4% of it on its own, with 5 other manufacturers making up the rest.
Across 47 payments — averaging $58.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$2K
- Jazz Pharmaceuticals Inc.$293
- Harmony Biosciences LLC$161
- Axsome Therapeutics, Inc.$74
- Avadel CNS Pharmaceuticals, LLC$45
- Lilly USA, LLC$21
What the payments were for
- Travel & lodging$1,20844%
- Food & beverage$1,53956%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 23 | $2,153 |
| Jazz Pharmaceuticals Inc. | 9 | $293 |
| Harmony Biosciences LLC | 8 | $161 |
| Axsome Therapeutics, Inc. | 4 | $74 |
| Avadel CNS Pharmaceuticals, LLC | 2 | $45 |
| Lilly USA, LLC | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Inspire$1,803
How this compares
$2,747 in reported general payments places this provider in the 75th percentile of 253 medical providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 40 | $213 |
| Fluticasone Propionate | 18 | $192 |
| Azithromycin | 22 | $98 |
| Cephalexin | 12 | $53 |
Paid to pharmacies, not to this prescriber.
Other medical in New Roads
- Kristi RobertBaton Rouge$486K
- Vickie RiceBaton Rouge$19K
- Mary McFerrenShreveport$16K
- Rachel RhinehartJefferson$16K
- Sydney FussellCovington$16K
- Thomas BriscoeLafayette$13K
- Seth HendrixShreveport$12K
- Jessica PelusoNatchitoches$12K
- Heather RoanBossier City$11K
- Emily FerraraBaton Rouge$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.